학술논문

An International Multicenter Evaluation of Type 5 Long QT Syndrome
Document Type
article
Source
Circulation. 141(6)
Subject
Genetics
Cardiovascular
Clinical Trials and Supportive Activities
Heart Disease
Clinical Research
Human Genome
2.1 Biological and endogenous factors
Aetiology
Adolescent
Adult
Death
Sudden
Cardiac
Electric Countershock
Electrocardiography
Female
Heart Arrest
Humans
Long QT Syndrome
Male
Middle Aged
Penetrance
Potassium Channels
Voltage-Gated
Registries
arrhythmia
genetics
long QT syndrome
penetrance
sudden cardiac death
Cardiorespiratory Medicine and Haematology
Clinical Sciences
Public Health and Health Services
Cardiovascular System & Hematology
Language
Abstract
BackgroundInsight into type 5 long QT syndrome (LQT5) has been limited to case reports and small family series. Improved understanding of the clinical phenotype and genetic features associated with rare KCNE1 variants implicated in LQT5 was sought through an international multicenter collaboration.MethodsPatients with either presumed autosomal dominant LQT5 (N = 229) or the recessive Type 2 Jervell and Lange-Nielsen syndrome (N = 19) were enrolled from 22 genetic arrhythmia clinics and 4 registries from 9 countries. KCNE1 variants were evaluated for ECG penetrance (defined as QTc >460 ms on presenting ECG) and genotype-phenotype segregation. Multivariable Cox regression was used to compare the associations between clinical and genetic variables with a composite primary outcome of definite arrhythmic events, including appropriate implantable cardioverter-defibrillator shocks, aborted cardiac arrest, and sudden cardiac death.ResultsA total of 32 distinct KCNE1 rare variants were identified in 89 probands and 140 genotype positive family members with presumed LQT5 and an additional 19 Type 2 Jervell and Lange-Nielsen syndrome patients. Among presumed LQT5 patients, the mean QTc on presenting ECG was significantly longer in probands (476.9±38.6 ms) compared with genotype positive family members (441.8±30.9 ms, P